Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Hering

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
The Journal of Urology|July 14, 2000
Perforation of sigmoid colon after extracorporeal lithotripsyM Lipay, S Araujo, M Perosa, et al.
Helvetica Paediatrica Acta|December 1, 1986
[Diagnosis and therapy of candidiasis in the premature infant]F Hering, A Otten, J Bauer, et al.
Andrologia|January 1, 1996
Intracytoplasmic sperm injection (ICSI) with testicular sperm extraction (TESE) in non-obstructive azoospermia--two case reportsM Häberle, P Scheurer, P Mühlebach, et al.
Helvetica Chirurgica Acta|August 1, 1989
[Therapy of metastatic prostatic cancer by orchiectomy plus Anandron versus orchiectomy plus placebo. Initial results of a randomized multicenter study]H Knönagel, J F Bolle, F Hering, et al.
Actas Urologicas Espanolas|July 29, 2008
[Testicular toxoplasmosis: a rare case of a testicular mass]F Barreto, F Hering, M F Dall'oglio, et al.
Clinical Chemistry|September 1, 1994
Tamm-Horsfall glycoprotein: role in inhibition and promotion of renal calcium oxalate stone formation studied with Fourier-transform infrared spectroscopyR Knörle, P Schnierle, A Koch, et al.
Cancer|May 1, 1997
A phase II study of oral idarubicin as a treatment for metastatic hormone-refractory prostate carcinoma with special focus on prostate specific antigen doubling time. Swiss Group for Clinical Cancer Research, Berne, SwitzerlandH P Schmid, R Maibach, J Bernhard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma. Swiss Group for Clinical Cancer Research (SAKK)R Morant, J Bernhard, R Maibach, et al.
British Journal of Cancer|April 1, 2004
Capecitabine in hormone-resistant metastatic prostatic carcinoma - a phase II trialR Morant, J Bernhard, D Dietrich, et al.
European Journal of Cancer (Oxford, England : 1990)|July 27, 2002
Vinorelbine in androgen-independent metastatic prostatic carcinoma--a phase II studyR Morant, S-F Hsu Schmitz, J Bernhard, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
The Journal of Urology|July 14, 2000
Perforation of sigmoid colon after extracorporeal lithotripsyM Lipay, S Araujo, M Perosa, et al.
Helvetica Paediatrica Acta|December 1, 1986
[Diagnosis and therapy of candidiasis in the premature infant]F Hering, A Otten, J Bauer, et al.
Andrologia|January 1, 1996
Intracytoplasmic sperm injection (ICSI) with testicular sperm extraction (TESE) in non-obstructive azoospermia--two case reportsM Häberle, P Scheurer, P Mühlebach, et al.
Helvetica Chirurgica Acta|August 1, 1989
[Therapy of metastatic prostatic cancer by orchiectomy plus Anandron versus orchiectomy plus placebo. Initial results of a randomized multicenter study]H Knönagel, J F Bolle, F Hering, et al.
Actas Urologicas Espanolas|July 29, 2008
[Testicular toxoplasmosis: a rare case of a testicular mass]F Barreto, F Hering, M F Dall'oglio, et al.
Clinical Chemistry|September 1, 1994
Tamm-Horsfall glycoprotein: role in inhibition and promotion of renal calcium oxalate stone formation studied with Fourier-transform infrared spectroscopyR Knörle, P Schnierle, A Koch, et al.
Cancer|May 1, 1997
A phase II study of oral idarubicin as a treatment for metastatic hormone-refractory prostate carcinoma with special focus on prostate specific antigen doubling time. Swiss Group for Clinical Cancer Research, Berne, SwitzerlandH P Schmid, R Maibach, J Bernhard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma. Swiss Group for Clinical Cancer Research (SAKK)R Morant, J Bernhard, R Maibach, et al.
British Journal of Cancer|April 1, 2004
Capecitabine in hormone-resistant metastatic prostatic carcinoma - a phase II trialR Morant, J Bernhard, D Dietrich, et al.
European Journal of Cancer (Oxford, England : 1990)|July 27, 2002
Vinorelbine in androgen-independent metastatic prostatic carcinoma--a phase II studyR Morant, S-F Hsu Schmitz, J Bernhard, et al.
Pageof 6